Majority of SH have invested into Biotron based on our technology our lead drug Bit225 and company announcements, wasn’t all that long ago MM was up and about and the SP was a reflection. Plenty going on throughout the World which intern will only generate more interest in our technology……..I am still confident MM will have no problem in selling our technology once she secures a few extra bucks into the company’s account.
- Forums
- ASX - By Stock
- BIT
- Complete headline results for Commercial Deal, when?
Complete headline results for Commercial Deal, when?, page-168
Featured News
Add BIT (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.14M |
Open | High | Low | Value | Volume |
1.9¢ | 1.9¢ | 1.9¢ | $4.225K | 222.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 1639605 | 1.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.0¢ | 80000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 1639605 | 0.019 |
11 | 2301165 | 0.018 |
5 | 688000 | 0.017 |
11 | 1524225 | 0.016 |
4 | 660000 | 0.015 |
Price($) | Vol. | No. |
---|---|---|
0.020 | 80000 | 1 |
0.021 | 188000 | 3 |
0.022 | 600000 | 2 |
0.023 | 307000 | 2 |
0.024 | 255035 | 3 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online